cf39637494aa7b82…

Study
ID: NCT000019171,447 bytesFirst seen Jun 12, 20261 collection

Fields

NameValue
briefSummaryThe purpose of this study is to use brain imaging technology to study the effects of aging and Alzheimer's Disease (AD) on a specific type of brain receptor. The brain is made up of cells called neurons. The neurons communicate with one another and secrete chemicals called neurotransmitters. The neurotransmitters bind to specific sites on other neurons called receptors. Acetylcholine (ACh) is a neurotransmitter that binds to ACh receptors. In both aging and AD, the number of neurons that secrete ACh decreases and the function of some ACh receptors changes. This study will use positron emission tomography (PET) scans of the brain to study the effects of age and AD on muscarinic type 2 \[M2\], a type of ACh receptor. Participants in this study will be injected with a radioactive tracer (ligand \[F-18\] FP-TZTP) which binds to \[M2\] receptors. Participants will then undergo a PET scan in order for the density and function of \[M2\] receptors to be studied.
completionDate2005-04
conditions["Alzheimer's Disease","Healthy"]
enrollmentCount150
enrollmentTypenull
nctIdNCT00001917
phasenull
sponsorIdnational-institute-of-mental-health-nimh
startDate1999-04
statusCOMPLETED
studyTypeOBSERVATIONAL
titleM2 Receptor Measurements in Aging and in Alzheimer's Disease
urlhttps://clinicaltrials.gov/study/NCT00001917

Canonical JSON

{
  "id": "NCT00001917",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of this study is to use brain imaging technology to study the effects of aging and Alzheimer's Disease (AD) on a specific type of brain receptor.\n\nThe brain is made up of cells called neurons. The neurons communicate with one another and secrete chemicals called neurotransmitters. The neurotransmitters bind to specific sites on other neurons called receptors. Acetylcholine (ACh) is a neurotransmitter that binds to ACh receptors. In both aging and AD, the number of neurons that secrete ACh decreases and the function of some ACh receptors changes. This study will use positron emission tomography (PET) scans of the brain to study the effects of age and AD on muscarinic type 2 \\[M2\\], a type of ACh receptor.\n\nParticipants in this study will be injected with a radioactive tracer (ligand \\[F-18\\] FP-TZTP) which binds to \\[M2\\] receptors. Participants will then undergo a PET scan in order for the density and function of \\[M2\\] receptors to be studied.",
    "completionDate": "2005-04",
    "conditions": [
      "Alzheimer's Disease",
      "Healthy"
    ],
    "enrollmentCount": 150,
    "enrollmentType": null,
    "nctId": "NCT00001917",
    "phase": null,
    "sponsorId": "national-institute-of-mental-health-nimh",
    "startDate": "1999-04",
    "status": "COMPLETED",
    "studyType": "OBSERVATIONAL",
    "title": "M2 Receptor Measurements in Aging and in Alzheimer's Disease",
    "url": "https://clinicaltrials.gov/study/NCT00001917"
  }
}

Appears in 1 collection

nih/clinical-trials1 version · Jun 12, 2026

Full hash:cf39637494aa7b829a4172cf7485fcf5f358b55d3e24f1949cdec88bf568a4d0